Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar Gel in active SLE
NCT02953821Phase 4Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Dec 2016
- Primary completion
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
Phase 4, randomised, double-blind trial in systemic lupus erythematosus (SLE) comparing Acthar Gel with Placebo Gel (2 arms). Primary endpoints: Physician's Global Assessment at Week 24, British Isles Lupus Assessment Group 2004 at Week 24 and 1 more. Started Dec 2016; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT02953821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953821.